Global Cellular and Gene Therapy Product Production, Demand and Key Producers, 2022-2028
This report studies the global Cellular and Gene Therapy Product demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cellular and Gene Therapy Product, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cellular and Gene Therapy Product that contribute to its increasing demand across many markets.
The global Cellular and Gene Therapy Product market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cellular and Gene Therapy Product total market, 2017-2028, (USD Million)
Global Cellular and Gene Therapy Product total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Cellular and Gene Therapy Product total market, key domestic companies and share, (USD Million)
Global Cellular and Gene Therapy Product revenue by player and market share 2017-2022, (USD Million)
Global Cellular and Gene Therapy Product total market by Type, CAGR, 2017-2028, (USD Million)
Global Cellular and Gene Therapy Product total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Cellular and Gene Therapy Product market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center and LifeSouth Community Blood Centers, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cellular and Gene Therapy Product market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cellular and Gene Therapy Product Market, By Region:
1. How big is the global Cellular and Gene Therapy Product market?
2. What is the demand of the global Cellular and Gene Therapy Product market?
3. What is the year over year growth of the global Cellular and Gene Therapy Product market?
4. What is the total value of the global Cellular and Gene Therapy Product market?
5. Who are the major players in the global Cellular and Gene Therapy Product market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Cellular and Gene Therapy Product, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cellular and Gene Therapy Product that contribute to its increasing demand across many markets.
The global Cellular and Gene Therapy Product market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cellular and Gene Therapy Product total market, 2017-2028, (USD Million)
Global Cellular and Gene Therapy Product total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Cellular and Gene Therapy Product total market, key domestic companies and share, (USD Million)
Global Cellular and Gene Therapy Product revenue by player and market share 2017-2022, (USD Million)
Global Cellular and Gene Therapy Product total market by Type, CAGR, 2017-2028, (USD Million)
Global Cellular and Gene Therapy Product total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Cellular and Gene Therapy Product market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center and LifeSouth Community Blood Centers, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cellular and Gene Therapy Product market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cellular and Gene Therapy Product Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cellular Immunotherapies
- Cancer Vaccines
- Autologous and Allogeneic Cells
- Blood Cancer
- Prostate Cancer
- Skin Cancer
- Other
- Bristol-Myers Squibb
- New York Blood Center
- Johnson & Johnson
- Cleveland Cord Blood Center
- Organogenesis
- Duke University School of Medicine
- Colorado Cord Blood Banking
- MD Anderson Cancer Center
- LifeSouth Community Blood Centers
- Bloodworks Northwest
- Amgen
- Novartis Pharmaceuticals
- Castle Creek Biosciences
- Spark Therapeutics
- Vericel
- Dendreon Pharmaceuticals
- Enzyvant Therapeutics GmbH
- Mallinckrodt
- Gilead Sciences
- bluebird bio
1. How big is the global Cellular and Gene Therapy Product market?
2. What is the demand of the global Cellular and Gene Therapy Product market?
3. What is the year over year growth of the global Cellular and Gene Therapy Product market?
4. What is the total value of the global Cellular and Gene Therapy Product market?
5. Who are the major players in the global Cellular and Gene Therapy Product market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cellular and Gene Therapy Product Introduction
1.2 World Cellular and Gene Therapy Product Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Cellular and Gene Therapy Product Total Market by Region
1.3.1 World Cellular and Gene Therapy Product Market Size by Region (2017-2028)
1.3.2 United States Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.3 China Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.4 Europe Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.5 Japan Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.6 South Korea Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.7 ASEAN Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.8 India Cellular and Gene Therapy Product Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cellular and Gene Therapy Product Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cellular and Gene Therapy Product Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CELLULAR AND GENE THERAPY PRODUCT COMPANIES COMPETITIVE ANALYSIS
2.1 World Cellular and Gene Therapy Product Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Cellular and Gene Therapy Product Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Cellular and Gene Therapy Product in 2021
2.2.3 Global Concentration Ratios (CR8) for Cellular and Gene Therapy Product in 2021
2.3 Cellular and Gene Therapy Product Company Evaluation Quadrant
2.4 Cellular and Gene Therapy Product Market: Overall Company Footprint Analysis
2.4.1 Cellular and Gene Therapy Product Market: Region Footprint
2.4.2 Cellular and Gene Therapy Product Market: Company Product Type Footprint
2.4.3 Cellular and Gene Therapy Product Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Cellular and Gene Therapy Product Market Comparison
3.1.1 United States VS China: Cellular and Gene Therapy Product Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Cellular and Gene Therapy Product Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Cellular and Gene Therapy Product Major Players and Market Share, 2017-2022
3.2.1 Major Players of Cellular and Gene Therapy Product in United States, Headquarters (States, Country)
3.2.2 United States Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022)
3.3 China Cellular and Gene Therapy Product Major Players and Market Share, 2017-2022
3.3.1 Major Players of Cellular and Gene Therapy Product in China, Headquarters (Province, Country)
3.3.2 China Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Cellular and Gene Therapy Product Major Players and Market Share, 2017-2022
3.4.1 Major Players of Cellular and Gene Therapy Product in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Cellular and Gene Therapy Product Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Cellular Immunotherapies
4.2.2 Cancer Vaccines
4.2.3 Autologous and Allogeneic Cells
4.3 Market Segment by Type
4.3.1 World Cellular and Gene Therapy Product Market Size by Type (2017-2022)
4.3.2 World Cellular and Gene Therapy Product Market Size by Type (2023-2028)
4.3.3 World Cellular and Gene Therapy Product Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Cellular and Gene Therapy Product Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Blood Cancer
5.2.2 Prostate Cancer
5.2.3 Skin Cancer
5.2.4 Other
5.2.5 Other
5.3 Market Segment by Application
5.3.1 World Cellular and Gene Therapy Product Market Size by Application (2017-2022)
5.3.2 World Cellular and Gene Therapy Product Market Size by Application (2023-2028)
5.3.3 World Cellular and Gene Therapy Product Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Details
6.1.2 Bristol-Myers Squibb Major Business
6.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
6.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.1.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
6.2 New York Blood Center
6.2.1 New York Blood Center Details
6.2.2 New York Blood Center Major Business
6.2.3 New York Blood Center Cellular and Gene Therapy Product Product and Services
6.2.4 New York Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 New York Blood Center Recent Developments/Updates
6.2.6 New York Blood Center Competitive Strengths & Weaknesses
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Details
6.3.2 Johnson & Johnson Major Business
6.3.3 Johnson & Johnson Cellular and Gene Therapy Product Product and Services
6.3.4 Johnson & Johnson Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Johnson & Johnson Recent Developments/Updates
6.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
6.4 Cleveland Cord Blood Center
6.4.1 Cleveland Cord Blood Center Details
6.4.2 Cleveland Cord Blood Center Major Business
6.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
6.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Cleveland Cord Blood Center Recent Developments/Updates
6.4.6 Cleveland Cord Blood Center Competitive Strengths & Weaknesses
6.5 Organogenesis
6.5.1 Organogenesis Details
6.5.2 Organogenesis Major Business
6.5.3 Organogenesis Cellular and Gene Therapy Product Product and Services
6.5.4 Organogenesis Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Organogenesis Recent Developments/Updates
6.5.6 Organogenesis Competitive Strengths & Weaknesses
6.6 Duke University School of Medicine
6.6.1 Duke University School of Medicine Details
6.6.2 Duke University School of Medicine Major Business
6.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
6.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Duke University School of Medicine Recent Developments/Updates
6.6.6 Duke University School of Medicine Competitive Strengths & Weaknesses
6.7 Colorado Cord Blood Banking
6.7.1 Colorado Cord Blood Banking Details
6.7.2 Colorado Cord Blood Banking Major Business
6.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
6.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Colorado Cord Blood Banking Recent Developments/Updates
6.7.6 Colorado Cord Blood Banking Competitive Strengths & Weaknesses
6.8 MD Anderson Cancer Center
6.8.1 MD Anderson Cancer Center Details
6.8.2 MD Anderson Cancer Center Major Business
6.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
6.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 MD Anderson Cancer Center Recent Developments/Updates
6.8.6 MD Anderson Cancer Center Competitive Strengths & Weaknesses
6.9 LifeSouth Community Blood Centers
6.9.1 LifeSouth Community Blood Centers Details
6.9.2 LifeSouth Community Blood Centers Major Business
6.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
6.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 LifeSouth Community Blood Centers Recent Developments/Updates
6.9.6 LifeSouth Community Blood Centers Competitive Strengths & Weaknesses
6.10 Bloodworks Northwest
6.10.1 Bloodworks Northwest Details
6.10.2 Bloodworks Northwest Major Business
6.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
6.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Bloodworks Northwest Recent Developments/Updates
6.10.6 Bloodworks Northwest Competitive Strengths & Weaknesses
6.11 Amgen
6.11.1 Amgen Details
6.11.2 Amgen Major Business
6.11.3 Amgen Cellular and Gene Therapy Product Product and Services
6.11.4 Amgen Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Amgen Recent Developments/Updates
6.11.6 Amgen Competitive Strengths & Weaknesses
6.12 Novartis Pharmaceuticals
6.12.1 Novartis Pharmaceuticals Details
6.12.2 Novartis Pharmaceuticals Major Business
6.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
6.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Novartis Pharmaceuticals Recent Developments/Updates
6.12.6 Novartis Pharmaceuticals Competitive Strengths & Weaknesses
6.13 Castle Creek Biosciences
6.13.1 Castle Creek Biosciences Details
6.13.2 Castle Creek Biosciences Major Business
6.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
6.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Castle Creek Biosciences Recent Developments/Updates
6.13.6 Castle Creek Biosciences Competitive Strengths & Weaknesses
6.14 Spark Therapeutics
6.14.1 Spark Therapeutics Details
6.14.2 Spark Therapeutics Major Business
6.14.3 Spark Therapeutics Cellular and Gene Therapy Product Product and Services
6.14.4 Spark Therapeutics Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Spark Therapeutics Recent Developments/Updates
6.14.6 Spark Therapeutics Competitive Strengths & Weaknesses
6.15 Vericel
6.15.1 Vericel Details
6.15.2 Vericel Major Business
6.15.3 Vericel Cellular and Gene Therapy Product Product and Services
6.15.4 Vericel Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Vericel Recent Developments/Updates
6.15.6 Vericel Competitive Strengths & Weaknesses
6.16 Dendreon Pharmaceuticals
6.16.1 Dendreon Pharmaceuticals Details
6.16.2 Dendreon Pharmaceuticals Major Business
6.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
6.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Dendreon Pharmaceuticals Recent Developments/Updates
6.16.6 Dendreon Pharmaceuticals Competitive Strengths & Weaknesses
6.17 Enzyvant Therapeutics GmbH
6.17.1 Enzyvant Therapeutics GmbH Details
6.17.2 Enzyvant Therapeutics GmbH Major Business
6.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
6.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Enzyvant Therapeutics GmbH Recent Developments/Updates
6.17.6 Enzyvant Therapeutics GmbH Competitive Strengths & Weaknesses
6.18 Mallinckrodt
6.18.1 Mallinckrodt Details
6.18.2 Mallinckrodt Major Business
6.18.3 Mallinckrodt Cellular and Gene Therapy Product Product and Services
6.18.4 Mallinckrodt Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Mallinckrodt Recent Developments/Updates
6.18.6 Mallinckrodt Competitive Strengths & Weaknesses
6.19 Gilead Sciences
6.19.1 Gilead Sciences Details
6.19.2 Gilead Sciences Major Business
6.19.3 Gilead Sciences Cellular and Gene Therapy Product Product and Services
6.19.4 Gilead Sciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Gilead Sciences Recent Developments/Updates
6.19.6 Gilead Sciences Competitive Strengths & Weaknesses
6.20 bluebird bio
6.20.1 bluebird bio Details
6.20.2 bluebird bio Major Business
6.20.3 bluebird bio Cellular and Gene Therapy Product Product and Services
6.20.4 bluebird bio Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 bluebird bio Recent Developments/Updates
6.20.6 bluebird bio Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Cellular and Gene Therapy Product and Key Manufacturers
7.2 Cellular and Gene Therapy Product Manufacturing Costs
7.3 Cellular and Gene Therapy Product Production Process
7.4 Cellular and Gene Therapy Product Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Cellular and Gene Therapy Product Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Cellular and Gene Therapy Product Typical Distributors
8.3 Cellular and Gene Therapy Product Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cellular and Gene Therapy Product Introduction
1.2 World Cellular and Gene Therapy Product Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Cellular and Gene Therapy Product Total Market by Region
1.3.1 World Cellular and Gene Therapy Product Market Size by Region (2017-2028)
1.3.2 United States Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.3 China Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.4 Europe Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.5 Japan Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.6 South Korea Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.7 ASEAN Cellular and Gene Therapy Product Market Size (2017-2028)
1.3.8 India Cellular and Gene Therapy Product Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cellular and Gene Therapy Product Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cellular and Gene Therapy Product Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CELLULAR AND GENE THERAPY PRODUCT COMPANIES COMPETITIVE ANALYSIS
2.1 World Cellular and Gene Therapy Product Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Cellular and Gene Therapy Product Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Cellular and Gene Therapy Product in 2021
2.2.3 Global Concentration Ratios (CR8) for Cellular and Gene Therapy Product in 2021
2.3 Cellular and Gene Therapy Product Company Evaluation Quadrant
2.4 Cellular and Gene Therapy Product Market: Overall Company Footprint Analysis
2.4.1 Cellular and Gene Therapy Product Market: Region Footprint
2.4.2 Cellular and Gene Therapy Product Market: Company Product Type Footprint
2.4.3 Cellular and Gene Therapy Product Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Cellular and Gene Therapy Product Market Comparison
3.1.1 United States VS China: Cellular and Gene Therapy Product Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Cellular and Gene Therapy Product Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Cellular and Gene Therapy Product Major Players and Market Share, 2017-2022
3.2.1 Major Players of Cellular and Gene Therapy Product in United States, Headquarters (States, Country)
3.2.2 United States Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022)
3.3 China Cellular and Gene Therapy Product Major Players and Market Share, 2017-2022
3.3.1 Major Players of Cellular and Gene Therapy Product in China, Headquarters (Province, Country)
3.3.2 China Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Cellular and Gene Therapy Product Major Players and Market Share, 2017-2022
3.4.1 Major Players of Cellular and Gene Therapy Product in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Cellular and Gene Therapy Product Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Cellular Immunotherapies
4.2.2 Cancer Vaccines
4.2.3 Autologous and Allogeneic Cells
4.3 Market Segment by Type
4.3.1 World Cellular and Gene Therapy Product Market Size by Type (2017-2022)
4.3.2 World Cellular and Gene Therapy Product Market Size by Type (2023-2028)
4.3.3 World Cellular and Gene Therapy Product Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Cellular and Gene Therapy Product Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Blood Cancer
5.2.2 Prostate Cancer
5.2.3 Skin Cancer
5.2.4 Other
5.2.5 Other
5.3 Market Segment by Application
5.3.1 World Cellular and Gene Therapy Product Market Size by Application (2017-2022)
5.3.2 World Cellular and Gene Therapy Product Market Size by Application (2023-2028)
5.3.3 World Cellular and Gene Therapy Product Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Details
6.1.2 Bristol-Myers Squibb Major Business
6.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
6.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.1.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
6.2 New York Blood Center
6.2.1 New York Blood Center Details
6.2.2 New York Blood Center Major Business
6.2.3 New York Blood Center Cellular and Gene Therapy Product Product and Services
6.2.4 New York Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 New York Blood Center Recent Developments/Updates
6.2.6 New York Blood Center Competitive Strengths & Weaknesses
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Details
6.3.2 Johnson & Johnson Major Business
6.3.3 Johnson & Johnson Cellular and Gene Therapy Product Product and Services
6.3.4 Johnson & Johnson Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Johnson & Johnson Recent Developments/Updates
6.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
6.4 Cleveland Cord Blood Center
6.4.1 Cleveland Cord Blood Center Details
6.4.2 Cleveland Cord Blood Center Major Business
6.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
6.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Cleveland Cord Blood Center Recent Developments/Updates
6.4.6 Cleveland Cord Blood Center Competitive Strengths & Weaknesses
6.5 Organogenesis
6.5.1 Organogenesis Details
6.5.2 Organogenesis Major Business
6.5.3 Organogenesis Cellular and Gene Therapy Product Product and Services
6.5.4 Organogenesis Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Organogenesis Recent Developments/Updates
6.5.6 Organogenesis Competitive Strengths & Weaknesses
6.6 Duke University School of Medicine
6.6.1 Duke University School of Medicine Details
6.6.2 Duke University School of Medicine Major Business
6.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
6.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Duke University School of Medicine Recent Developments/Updates
6.6.6 Duke University School of Medicine Competitive Strengths & Weaknesses
6.7 Colorado Cord Blood Banking
6.7.1 Colorado Cord Blood Banking Details
6.7.2 Colorado Cord Blood Banking Major Business
6.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
6.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Colorado Cord Blood Banking Recent Developments/Updates
6.7.6 Colorado Cord Blood Banking Competitive Strengths & Weaknesses
6.8 MD Anderson Cancer Center
6.8.1 MD Anderson Cancer Center Details
6.8.2 MD Anderson Cancer Center Major Business
6.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
6.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 MD Anderson Cancer Center Recent Developments/Updates
6.8.6 MD Anderson Cancer Center Competitive Strengths & Weaknesses
6.9 LifeSouth Community Blood Centers
6.9.1 LifeSouth Community Blood Centers Details
6.9.2 LifeSouth Community Blood Centers Major Business
6.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
6.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 LifeSouth Community Blood Centers Recent Developments/Updates
6.9.6 LifeSouth Community Blood Centers Competitive Strengths & Weaknesses
6.10 Bloodworks Northwest
6.10.1 Bloodworks Northwest Details
6.10.2 Bloodworks Northwest Major Business
6.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
6.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Bloodworks Northwest Recent Developments/Updates
6.10.6 Bloodworks Northwest Competitive Strengths & Weaknesses
6.11 Amgen
6.11.1 Amgen Details
6.11.2 Amgen Major Business
6.11.3 Amgen Cellular and Gene Therapy Product Product and Services
6.11.4 Amgen Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Amgen Recent Developments/Updates
6.11.6 Amgen Competitive Strengths & Weaknesses
6.12 Novartis Pharmaceuticals
6.12.1 Novartis Pharmaceuticals Details
6.12.2 Novartis Pharmaceuticals Major Business
6.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
6.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Novartis Pharmaceuticals Recent Developments/Updates
6.12.6 Novartis Pharmaceuticals Competitive Strengths & Weaknesses
6.13 Castle Creek Biosciences
6.13.1 Castle Creek Biosciences Details
6.13.2 Castle Creek Biosciences Major Business
6.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
6.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Castle Creek Biosciences Recent Developments/Updates
6.13.6 Castle Creek Biosciences Competitive Strengths & Weaknesses
6.14 Spark Therapeutics
6.14.1 Spark Therapeutics Details
6.14.2 Spark Therapeutics Major Business
6.14.3 Spark Therapeutics Cellular and Gene Therapy Product Product and Services
6.14.4 Spark Therapeutics Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Spark Therapeutics Recent Developments/Updates
6.14.6 Spark Therapeutics Competitive Strengths & Weaknesses
6.15 Vericel
6.15.1 Vericel Details
6.15.2 Vericel Major Business
6.15.3 Vericel Cellular and Gene Therapy Product Product and Services
6.15.4 Vericel Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Vericel Recent Developments/Updates
6.15.6 Vericel Competitive Strengths & Weaknesses
6.16 Dendreon Pharmaceuticals
6.16.1 Dendreon Pharmaceuticals Details
6.16.2 Dendreon Pharmaceuticals Major Business
6.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
6.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Dendreon Pharmaceuticals Recent Developments/Updates
6.16.6 Dendreon Pharmaceuticals Competitive Strengths & Weaknesses
6.17 Enzyvant Therapeutics GmbH
6.17.1 Enzyvant Therapeutics GmbH Details
6.17.2 Enzyvant Therapeutics GmbH Major Business
6.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
6.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Enzyvant Therapeutics GmbH Recent Developments/Updates
6.17.6 Enzyvant Therapeutics GmbH Competitive Strengths & Weaknesses
6.18 Mallinckrodt
6.18.1 Mallinckrodt Details
6.18.2 Mallinckrodt Major Business
6.18.3 Mallinckrodt Cellular and Gene Therapy Product Product and Services
6.18.4 Mallinckrodt Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Mallinckrodt Recent Developments/Updates
6.18.6 Mallinckrodt Competitive Strengths & Weaknesses
6.19 Gilead Sciences
6.19.1 Gilead Sciences Details
6.19.2 Gilead Sciences Major Business
6.19.3 Gilead Sciences Cellular and Gene Therapy Product Product and Services
6.19.4 Gilead Sciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Gilead Sciences Recent Developments/Updates
6.19.6 Gilead Sciences Competitive Strengths & Weaknesses
6.20 bluebird bio
6.20.1 bluebird bio Details
6.20.2 bluebird bio Major Business
6.20.3 bluebird bio Cellular and Gene Therapy Product Product and Services
6.20.4 bluebird bio Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 bluebird bio Recent Developments/Updates
6.20.6 bluebird bio Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Cellular and Gene Therapy Product and Key Manufacturers
7.2 Cellular and Gene Therapy Product Manufacturing Costs
7.3 Cellular and Gene Therapy Product Production Process
7.4 Cellular and Gene Therapy Product Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Cellular and Gene Therapy Product Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Cellular and Gene Therapy Product Typical Distributors
8.3 Cellular and Gene Therapy Product Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cellular and Gene Therapy Product Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cellular and Gene Therapy Product Market Size by Region (2017-2022) & (USD Million)
Table 3. World Cellular and Gene Therapy Product Market Size by Region (2023-2028) & (USD Million)
Table 4. World Cellular and Gene Therapy Product Market Size Market Share by Region (2017-2022)
Table 5. World Cellular and Gene Therapy Product Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Cellular and Gene Therapy Product Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Cellular and Gene Therapy Product Players in 2021
Table 9. World Cellular and Gene Therapy Product Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Cellular and Gene Therapy Product Company Evaluation Quadrant
Table 11. Head Office of Key Cellular and Gene Therapy Product Player
Table 12. Cellular and Gene Therapy Product Market: Company Product Type Footprint
Table 13. Cellular and Gene Therapy Product Market: Company Product Application Footprint
Table 14. Cellular and Gene Therapy Product Mergers & Acquisitions Activity
Table 15. United States VS China Cellular and Gene Therapy Product Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Cellular and Gene Therapy Product in United States, Headquarters (States, Country)
Table 17. United States Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Cellular and Gene Therapy Product Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Cellular and Gene Therapy Product in China, Company Headquarters (Province, Country)
Table 20. China Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Cellular and Gene Therapy Product Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Cellular and Gene Therapy Product in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Cellular and Gene Therapy Product Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Cellular and Gene Therapy Product Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Cellular and Gene Therapy Product Revenue by Type (2017-2022) & (USD Million)
Table 27. World Cellular and Gene Therapy Product Revenue by Type (2023-2028) & (USD Million)
Table 28. World Cellular and Gene Therapy Product Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Cellular and Gene Therapy Product Revenue by Application (2017-2022) & (USD Million)
Table 30. World Cellular and Gene Therapy Product Revenue by Application (2023-2028) & (USD Million)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Major Business
Table 33. Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
Table 34. Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Bristol-Myers Squibb Recent Developments/Updates
Table 36. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 37. New York Blood Center Basic Information, Manufacturing Base and Competitors
Table 38. New York Blood Center Major Business
Table 39. New York Blood Center Cellular and Gene Therapy Product Product and Services
Table 40. New York Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. New York Blood Center Recent Developments/Updates
Table 42. New York Blood Center Competitive Strengths & Weaknesses
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson Cellular and Gene Therapy Product Product and Services
Table 46. Johnson & Johnson Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Johnson & Johnson Recent Developments/Updates
Table 48. Johnson & Johnson Competitive Strengths & Weaknesses
Table 49. Cleveland Cord Blood Center Basic Information, Manufacturing Base and Competitors
Table 50. Cleveland Cord Blood Center Major Business
Table 51. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
Table 52. Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Cleveland Cord Blood Center Recent Developments/Updates
Table 54. Cleveland Cord Blood Center Competitive Strengths & Weaknesses
Table 55. Organogenesis Basic Information, Manufacturing Base and Competitors
Table 56. Organogenesis Major Business
Table 57. Organogenesis Cellular and Gene Therapy Product Product and Services
Table 58. Organogenesis Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Organogenesis Recent Developments/Updates
Table 60. Organogenesis Competitive Strengths & Weaknesses
Table 61. Duke University School of Medicine Basic Information, Manufacturing Base and Competitors
Table 62. Duke University School of Medicine Major Business
Table 63. Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
Table 64. Duke University School of Medicine Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Duke University School of Medicine Recent Developments/Updates
Table 66. Duke University School of Medicine Competitive Strengths & Weaknesses
Table 67. Colorado Cord Blood Banking Basic Information, Manufacturing Base and Competitors
Table 68. Colorado Cord Blood Banking Major Business
Table 69. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
Table 70. Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Colorado Cord Blood Banking Recent Developments/Updates
Table 72. Colorado Cord Blood Banking Competitive Strengths & Weaknesses
Table 73. MD Anderson Cancer Center Basic Information, Manufacturing Base and Competitors
Table 74. MD Anderson Cancer Center Major Business
Table 75. MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
Table 76. MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. MD Anderson Cancer Center Recent Developments/Updates
Table 78. MD Anderson Cancer Center Competitive Strengths & Weaknesses
Table 79. LifeSouth Community Blood Centers Basic Information, Manufacturing Base and Competitors
Table 80. LifeSouth Community Blood Centers Major Business
Table 81. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
Table 82. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. LifeSouth Community Blood Centers Recent Developments/Updates
Table 84. LifeSouth Community Blood Centers Competitive Strengths & Weaknesses
Table 85. Bloodworks Northwest Basic Information, Manufacturing Base and Competitors
Table 86. Bloodworks Northwest Major Business
Table 87. Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
Table 88. Bloodworks Northwest Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Bloodworks Northwest Recent Developments/Updates
Table 90. Bloodworks Northwest Competitive Strengths & Weaknesses
Table 91. Amgen Basic Information, Manufacturing Base and Competitors
Table 92. Amgen Major Business
Table 93. Amgen Cellular and Gene Therapy Product Product and Services
Table 94. Amgen Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Amgen Recent Developments/Updates
Table 96. Amgen Competitive Strengths & Weaknesses
Table 97. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Novartis Pharmaceuticals Major Business
Table 99. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
Table 100. Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Novartis Pharmaceuticals Recent Developments/Updates
Table 102. Novartis Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Castle Creek Biosciences Basic Information, Manufacturing Base and Competitors
Table 104. Castle Creek Biosciences Major Business
Table 105. Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
Table 106. Castle Creek Biosciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Castle Creek Biosciences Recent Developments/Updates
Table 108. Castle Creek Biosciences Competitive Strengths & Weaknesses
Table 109. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Spark Therapeutics Major Business
Table 111. Spark Therapeutics Cellular and Gene Therapy Product Product and Services
Table 112. Spark Therapeutics Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Spark Therapeutics Recent Developments/Updates
Table 114. Spark Therapeutics Competitive Strengths & Weaknesses
Table 115. Vericel Basic Information, Manufacturing Base and Competitors
Table 116. Vericel Major Business
Table 117. Vericel Cellular and Gene Therapy Product Product and Services
Table 118. Vericel Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Vericel Recent Developments/Updates
Table 120. Vericel Competitive Strengths & Weaknesses
Table 121. Dendreon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Dendreon Pharmaceuticals Major Business
Table 123. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
Table 124. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Dendreon Pharmaceuticals Recent Developments/Updates
Table 126. Dendreon Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Enzyvant Therapeutics GmbH Basic Information, Manufacturing Base and Competitors
Table 128. Enzyvant Therapeutics GmbH Major Business
Table 129. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
Table 130. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Enzyvant Therapeutics GmbH Recent Developments/Updates
Table 132. Enzyvant Therapeutics GmbH Competitive Strengths & Weaknesses
Table 133. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 134. Mallinckrodt Major Business
Table 135. Mallinckrodt Cellular and Gene Therapy Product Product and Services
Table 136. Mallinckrodt Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Mallinckrodt Recent Developments/Updates
Table 138. Mallinckrodt Competitive Strengths & Weaknesses
Table 139. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 140. Gilead Sciences Major Business
Table 141. Gilead Sciences Cellular and Gene Therapy Product Product and Services
Table 142. Gilead Sciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Gilead Sciences Recent Developments/Updates
Table 144. bluebird bio Basic Information, Manufacturing Base and Competitors
Table 145. bluebird bio Major Business
Table 146. bluebird bio Cellular and Gene Therapy Product Product and Services
Table 147. bluebird bio Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 148. Cellular and Gene Therapy Product Raw Material
Table 149. Key Manufacturers of Cellular and Gene Therapy Product Raw Materials
Table 150. Cellular and Gene Therapy Product Typical Distributors
Table 151. Cellular and Gene Therapy Product Typical Customers
List of Figure
Figure 1. Cellular and Gene Therapy Product Picture
Figure 2. World Cellular and Gene Therapy Product Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cellular and Gene Therapy Product Total Market Size (2017-2028) & (USD Million)
Figure 4. World Cellular and Gene Therapy Product Market Size Market Share by Region (2017-2028)
Figure 5. United States Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 6. China Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 7. Europe Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 8. Japan Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 11. India Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 12. Cellular and Gene Therapy Product Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Cellular and Gene Therapy Product by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Cellular and Gene Therapy Product Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Cellular and Gene Therapy Product Markets in 2021
Figure 17. United States VS China: Cellular and Gene Therapy Product Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Cellular and Gene Therapy Product Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Cellular and Gene Therapy Product Market Size Market Share by Type in 2021
Figure 20. Cellular Immunotherapies
Figure 21. Cancer Vaccines
Figure 22. Autologous and Allogeneic Cells
Figure 23. World Cellular and Gene Therapy Product Market Size Market Share by Type (2017-2028)
Figure 24. World Cellular and Gene Therapy Product Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Cellular and Gene Therapy Product Market Size Market Share by Application in 2021
Figure 26. Blood Cancer
Figure 27. Prostate Cancer
Figure 28. Skin Cancer
Figure 29. Other
Figure 30. World Cellular and Gene Therapy Product Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Cellular and Gene Therapy Product in 2021
Figure 32. Manufacturing Process Analysis of Cellular and Gene Therapy Product
Figure 33. Cellular and Gene Therapy Product Industrial Chain
Figure 34. Distribution Channel Breakdown for Cellular and Gene Therapy Product Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
Table 1. World Cellular and Gene Therapy Product Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cellular and Gene Therapy Product Market Size by Region (2017-2022) & (USD Million)
Table 3. World Cellular and Gene Therapy Product Market Size by Region (2023-2028) & (USD Million)
Table 4. World Cellular and Gene Therapy Product Market Size Market Share by Region (2017-2022)
Table 5. World Cellular and Gene Therapy Product Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Cellular and Gene Therapy Product Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Cellular and Gene Therapy Product Players in 2021
Table 9. World Cellular and Gene Therapy Product Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Cellular and Gene Therapy Product Company Evaluation Quadrant
Table 11. Head Office of Key Cellular and Gene Therapy Product Player
Table 12. Cellular and Gene Therapy Product Market: Company Product Type Footprint
Table 13. Cellular and Gene Therapy Product Market: Company Product Application Footprint
Table 14. Cellular and Gene Therapy Product Mergers & Acquisitions Activity
Table 15. United States VS China Cellular and Gene Therapy Product Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Cellular and Gene Therapy Product in United States, Headquarters (States, Country)
Table 17. United States Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Cellular and Gene Therapy Product Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Cellular and Gene Therapy Product in China, Company Headquarters (Province, Country)
Table 20. China Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Cellular and Gene Therapy Product Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Cellular and Gene Therapy Product in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Cellular and Gene Therapy Product Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Cellular and Gene Therapy Product Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Cellular and Gene Therapy Product Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Cellular and Gene Therapy Product Revenue by Type (2017-2022) & (USD Million)
Table 27. World Cellular and Gene Therapy Product Revenue by Type (2023-2028) & (USD Million)
Table 28. World Cellular and Gene Therapy Product Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Cellular and Gene Therapy Product Revenue by Application (2017-2022) & (USD Million)
Table 30. World Cellular and Gene Therapy Product Revenue by Application (2023-2028) & (USD Million)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Major Business
Table 33. Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
Table 34. Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Bristol-Myers Squibb Recent Developments/Updates
Table 36. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 37. New York Blood Center Basic Information, Manufacturing Base and Competitors
Table 38. New York Blood Center Major Business
Table 39. New York Blood Center Cellular and Gene Therapy Product Product and Services
Table 40. New York Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. New York Blood Center Recent Developments/Updates
Table 42. New York Blood Center Competitive Strengths & Weaknesses
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson Cellular and Gene Therapy Product Product and Services
Table 46. Johnson & Johnson Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Johnson & Johnson Recent Developments/Updates
Table 48. Johnson & Johnson Competitive Strengths & Weaknesses
Table 49. Cleveland Cord Blood Center Basic Information, Manufacturing Base and Competitors
Table 50. Cleveland Cord Blood Center Major Business
Table 51. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
Table 52. Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Cleveland Cord Blood Center Recent Developments/Updates
Table 54. Cleveland Cord Blood Center Competitive Strengths & Weaknesses
Table 55. Organogenesis Basic Information, Manufacturing Base and Competitors
Table 56. Organogenesis Major Business
Table 57. Organogenesis Cellular and Gene Therapy Product Product and Services
Table 58. Organogenesis Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Organogenesis Recent Developments/Updates
Table 60. Organogenesis Competitive Strengths & Weaknesses
Table 61. Duke University School of Medicine Basic Information, Manufacturing Base and Competitors
Table 62. Duke University School of Medicine Major Business
Table 63. Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
Table 64. Duke University School of Medicine Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Duke University School of Medicine Recent Developments/Updates
Table 66. Duke University School of Medicine Competitive Strengths & Weaknesses
Table 67. Colorado Cord Blood Banking Basic Information, Manufacturing Base and Competitors
Table 68. Colorado Cord Blood Banking Major Business
Table 69. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
Table 70. Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Colorado Cord Blood Banking Recent Developments/Updates
Table 72. Colorado Cord Blood Banking Competitive Strengths & Weaknesses
Table 73. MD Anderson Cancer Center Basic Information, Manufacturing Base and Competitors
Table 74. MD Anderson Cancer Center Major Business
Table 75. MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
Table 76. MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. MD Anderson Cancer Center Recent Developments/Updates
Table 78. MD Anderson Cancer Center Competitive Strengths & Weaknesses
Table 79. LifeSouth Community Blood Centers Basic Information, Manufacturing Base and Competitors
Table 80. LifeSouth Community Blood Centers Major Business
Table 81. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
Table 82. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. LifeSouth Community Blood Centers Recent Developments/Updates
Table 84. LifeSouth Community Blood Centers Competitive Strengths & Weaknesses
Table 85. Bloodworks Northwest Basic Information, Manufacturing Base and Competitors
Table 86. Bloodworks Northwest Major Business
Table 87. Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
Table 88. Bloodworks Northwest Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Bloodworks Northwest Recent Developments/Updates
Table 90. Bloodworks Northwest Competitive Strengths & Weaknesses
Table 91. Amgen Basic Information, Manufacturing Base and Competitors
Table 92. Amgen Major Business
Table 93. Amgen Cellular and Gene Therapy Product Product and Services
Table 94. Amgen Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Amgen Recent Developments/Updates
Table 96. Amgen Competitive Strengths & Weaknesses
Table 97. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Novartis Pharmaceuticals Major Business
Table 99. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
Table 100. Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Novartis Pharmaceuticals Recent Developments/Updates
Table 102. Novartis Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Castle Creek Biosciences Basic Information, Manufacturing Base and Competitors
Table 104. Castle Creek Biosciences Major Business
Table 105. Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
Table 106. Castle Creek Biosciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Castle Creek Biosciences Recent Developments/Updates
Table 108. Castle Creek Biosciences Competitive Strengths & Weaknesses
Table 109. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Spark Therapeutics Major Business
Table 111. Spark Therapeutics Cellular and Gene Therapy Product Product and Services
Table 112. Spark Therapeutics Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Spark Therapeutics Recent Developments/Updates
Table 114. Spark Therapeutics Competitive Strengths & Weaknesses
Table 115. Vericel Basic Information, Manufacturing Base and Competitors
Table 116. Vericel Major Business
Table 117. Vericel Cellular and Gene Therapy Product Product and Services
Table 118. Vericel Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Vericel Recent Developments/Updates
Table 120. Vericel Competitive Strengths & Weaknesses
Table 121. Dendreon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Dendreon Pharmaceuticals Major Business
Table 123. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
Table 124. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Dendreon Pharmaceuticals Recent Developments/Updates
Table 126. Dendreon Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Enzyvant Therapeutics GmbH Basic Information, Manufacturing Base and Competitors
Table 128. Enzyvant Therapeutics GmbH Major Business
Table 129. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
Table 130. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Enzyvant Therapeutics GmbH Recent Developments/Updates
Table 132. Enzyvant Therapeutics GmbH Competitive Strengths & Weaknesses
Table 133. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 134. Mallinckrodt Major Business
Table 135. Mallinckrodt Cellular and Gene Therapy Product Product and Services
Table 136. Mallinckrodt Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Mallinckrodt Recent Developments/Updates
Table 138. Mallinckrodt Competitive Strengths & Weaknesses
Table 139. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 140. Gilead Sciences Major Business
Table 141. Gilead Sciences Cellular and Gene Therapy Product Product and Services
Table 142. Gilead Sciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Gilead Sciences Recent Developments/Updates
Table 144. bluebird bio Basic Information, Manufacturing Base and Competitors
Table 145. bluebird bio Major Business
Table 146. bluebird bio Cellular and Gene Therapy Product Product and Services
Table 147. bluebird bio Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 148. Cellular and Gene Therapy Product Raw Material
Table 149. Key Manufacturers of Cellular and Gene Therapy Product Raw Materials
Table 150. Cellular and Gene Therapy Product Typical Distributors
Table 151. Cellular and Gene Therapy Product Typical Customers
List of Figure
Figure 1. Cellular and Gene Therapy Product Picture
Figure 2. World Cellular and Gene Therapy Product Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cellular and Gene Therapy Product Total Market Size (2017-2028) & (USD Million)
Figure 4. World Cellular and Gene Therapy Product Market Size Market Share by Region (2017-2028)
Figure 5. United States Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 6. China Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 7. Europe Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 8. Japan Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 11. India Cellular and Gene Therapy Product Market Size (2017-2028) & (USD Million)
Figure 12. Cellular and Gene Therapy Product Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Cellular and Gene Therapy Product by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Cellular and Gene Therapy Product Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Cellular and Gene Therapy Product Markets in 2021
Figure 17. United States VS China: Cellular and Gene Therapy Product Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Cellular and Gene Therapy Product Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Cellular and Gene Therapy Product Market Size Market Share by Type in 2021
Figure 20. Cellular Immunotherapies
Figure 21. Cancer Vaccines
Figure 22. Autologous and Allogeneic Cells
Figure 23. World Cellular and Gene Therapy Product Market Size Market Share by Type (2017-2028)
Figure 24. World Cellular and Gene Therapy Product Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Cellular and Gene Therapy Product Market Size Market Share by Application in 2021
Figure 26. Blood Cancer
Figure 27. Prostate Cancer
Figure 28. Skin Cancer
Figure 29. Other
Figure 30. World Cellular and Gene Therapy Product Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Cellular and Gene Therapy Product in 2021
Figure 32. Manufacturing Process Analysis of Cellular and Gene Therapy Product
Figure 33. Cellular and Gene Therapy Product Industrial Chain
Figure 34. Distribution Channel Breakdown for Cellular and Gene Therapy Product Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
